Invention Grant
- Patent Title: Pharmaceutical composition containing 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy]-N-(methylsulfonyl)acetamide
-
Application No.: US16044821Application Date: 2018-07-25
-
Publication No.: US10780087B2Publication Date: 2020-09-22
- Inventor: Shouji Furuta , Hironori Mukai
- Applicant: NIPPON SHINYAKU CO., LTD.
- Applicant Address: JP Kyoto
- Assignee: NIPPON SHINYAKU CO., LTD.
- Current Assignee: NIPPON SHINYAKU CO., LTD.
- Current Assignee Address: JP Kyoto
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@2bf77ea6
- Main IPC: A61K31/4965
- IPC: A61K31/4965 ; A61K47/38 ; A61P9/12 ; A61P11/00 ; A61K9/20 ; A61K9/16 ; A61P11/06 ; A61P9/10 ; A61P7/02 ; A61P13/12 ; A61K31/047
![Pharmaceutical composition containing 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy]-N-(methylsulfonyl)acetamide](/abs-image/US/2020/09/22/US10780087B2/abs.jpg.150x150.jpg)
Abstract:
A stabilized solid preparation containing 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide is provided, namely, a solid preparation containing 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide and D-mannitol having a specific surface area of 1.0 m2/g or less.
Public/Granted literature
Information query